Literature DB >> 17497113

[Surgical resection of the thyroid and parathyroid glands].

U Woenckhaus1, R Büttner, L C Bollheimer.   

Abstract

The main indication for surgery of the thyroid gland is the resection of nodular, suspicious or hyperfunctioning tissue. Following thyroidectomy, L-thyroxine therapy is initiated adjusted to the remnant thyroid function. To prevent recurrence of a multinodular goiter, supplementation with iodine is strongly recommended. The management of patients with differentiated thyroid cancer depends on risk stratification. Although large prospective studies are missing, low-risk patients probably do not benefit from total thyroid ablation and lifelong thyroxine suppression therapy. As a result of impaired parathyroid function or resection of the parathyroid glands for hyperparathyroidism, acute or chronic hypocalcaemia can develop. If treatment with oral calcium is insufficient, the addition of a vitamin D analogue is necessary. This requires close monitoring to avoid renal or other hypercalcaemic complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497113     DOI: 10.1007/s00108-007-1834-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  27 in total

Review 1.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

2.  Parathyroid surgery: we only need a minimal surgical approach.

Authors:  P Miccoli
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

3.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

Review 4.  Thyroid-hormone therapy and thyroid cancer: a reassessment.

Authors:  Bernadette Biondi; Sebastiano Filetti; Martin Schlumberger
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2005-11

5.  What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy.

Authors:  Bill Chiu; Cord Sturgeon; Peter Angelos
Journal:  Surgery       Date:  2006-07-27       Impact factor: 3.982

6.  Video-assisted thyroidectomy: indications and results.

Authors:  Paolo Miccoli; Piero Berti; Gian Luca Frustaci; Carlo Enrico Ambrosini; Gabriele Materazzi
Journal:  Langenbecks Arch Surg       Date:  2006-03-30       Impact factor: 3.445

7.  Parathyroid hormone levels 4 hours after surgery do not accurately predict post-thyroidectomy hypocalcemia.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Pietro Princi; Chiara Dobrinja; Cinzia Carrozza; Enrico Di Stasio; Annamaria D'Amore; Cecilia Zuppi; Rocco Bellantone
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

8.  Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients.

Authors:  Hélène Gibelin; Mauricio Sierra; Denis Mothes; Pierre Ingrand; Pierre Levillain; Corinne Jones; Sammy Hadjadj; Florence Torremocha; Richard Marechaud; Jacques Barbier; Jean-Louis Kraimps
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

9.  [Is primary total thyroidectomy justified in benign multinodular goiter? Results of a prospective quality assurance study of 45 hospitals offering different levels of care].

Authors:  O Thomusch; C Sekulla; H Dralle
Journal:  Chirurg       Date:  2003-05       Impact factor: 0.955

10.  Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study.

Authors:  Carlo Carella; Gherardo Mazziotti; Mario Rotondi; Andrea Del Buono; Guido Zito; Francesca Sorvillo; Giovanni Manganella; Luigi Santini; Giovanni Amato
Journal:  Clin Endocrinol (Oxf)       Date:  2002-10       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.